Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gavras

Showing results (191-200 of 312) with videos related to

Pageof 32
Sort By:
Journal of Clinical Pharmacology|April 29, 1998
Clinical utility of long-term enalapril/diltiazem ER in stage 3-4 essential hypertension. Long-term Use of Enalapril/Diltiazem ER in Stage 3-4 Hypertension GroupS G Chrysant, H Gavras, A L Niederman, et al.
Clinical Science and Molecular Medicine. Supplement|June 1, 1975
The use of angiotensin-converting enzyme inhibitor in the diagnosis and treatment of hypertensionH Gavras, H R Brunner, J H Laragh, et al.
The American Journal of Physiology|January 1, 1982
Muscle glycogenolysis during exercise: dual control by epinephrine and contractionsE A Richter, N B Ruderman, H Gavras, et al.
Agents and Actions. Supplements|January 1, 1987
The antihypertensive contribution of bradykinin as assessed by a specific bradykinin antagonistA Benetos, H Gavras, J M Stewart, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1980
Captopril: an oral angiotension converting enzyme inhibitor active in manH R Brunner, H Gavras, B Waeber, et al.
Archives of Internal Medicine|November 1, 1977
Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis?H Gavras, I Gavras, P J Cannon, et al.
Postgraduate Medical Journal|October 1, 1970
The nephrotoxicity of cephaloridineD H Lawson, R F Macadam, H Singh, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 1, 1995
Augmentation of coronary blood flow by ACE inhibition: role of angiotensin and bradykininN A Ruocco, B A Bergelson, T K Yu, et al.
Circulation|November 1, 1978
Angiotensin converting enzyme inhibition in patients with congestive heart failureH Gavras, D P Faxon, J Berkoben, et al.
Kidney International|April 1, 1978
Mechanism of blood pressure reduction by teprotide (SQ 20881) in ratsP Jaeger, R K Ferguson, H R Brunner, et al.
Pageof 32

Showing results (191-200 of 312) with videos related to

Sort By:
Pageof 32
Journal of Clinical Pharmacology|April 29, 1998
Clinical utility of long-term enalapril/diltiazem ER in stage 3-4 essential hypertension. Long-term Use of Enalapril/Diltiazem ER in Stage 3-4 Hypertension GroupS G Chrysant, H Gavras, A L Niederman, et al.
Clinical Science and Molecular Medicine. Supplement|June 1, 1975
The use of angiotensin-converting enzyme inhibitor in the diagnosis and treatment of hypertensionH Gavras, H R Brunner, J H Laragh, et al.
The American Journal of Physiology|January 1, 1982
Muscle glycogenolysis during exercise: dual control by epinephrine and contractionsE A Richter, N B Ruderman, H Gavras, et al.
Agents and Actions. Supplements|January 1, 1987
The antihypertensive contribution of bradykinin as assessed by a specific bradykinin antagonistA Benetos, H Gavras, J M Stewart, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1980
Captopril: an oral angiotension converting enzyme inhibitor active in manH R Brunner, H Gavras, B Waeber, et al.
Archives of Internal Medicine|November 1, 1977
Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis?H Gavras, I Gavras, P J Cannon, et al.
Postgraduate Medical Journal|October 1, 1970
The nephrotoxicity of cephaloridineD H Lawson, R F Macadam, H Singh, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 1, 1995
Augmentation of coronary blood flow by ACE inhibition: role of angiotensin and bradykininN A Ruocco, B A Bergelson, T K Yu, et al.
Circulation|November 1, 1978
Angiotensin converting enzyme inhibition in patients with congestive heart failureH Gavras, D P Faxon, J Berkoben, et al.
Kidney International|April 1, 1978
Mechanism of blood pressure reduction by teprotide (SQ 20881) in ratsP Jaeger, R K Ferguson, H R Brunner, et al.
Pageof 32